Financials
- Market Capitalization 1.77 B
- Employee 130
- Founded 2019
- CEO N/A
- Website www.septerna.com
- Headquarter Delaware, United States
- FIGI BBG014WY1V28
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-63.19
Fiyat/satışlar oranı
15.2
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2070 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.58 USD | -3.29% | -7.77% | -5.26% | +92.41% | 1.82 B USD | ||
| 2079 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.38 USD | +1.20% | +3.36% | +11.55% | -26.36% | 1.81 B USD | ||
| 2094 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.68 USD | -1.48% | +1.85% | +19.74% | -7.58% | 1.78 B USD | ||
| 2104 | GHRS GH Research PLC - Ordinary Shares | 27.25 USD | -2.47% | -3.47% | -3.27% | +92.44% | 1.69 B USD |